Prophylactic Cholecystectomy is Safe in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
CONCLUSION: Prophylactic cholecystectomy in patients undergoing CRS-HIPEC is not associated with increased morbidity or increased bile leak risk compared to historical data. While the benefits of prophylactic cholecystectomy are not yet elucidated, it may be considered to avoid potential future morbid operations for biliary disease.PMID:38587264 | DOI:10.1177/00031348241246171
Source: The American Surgeon - Category: Surgery Authors: David N Hanna Nazanin Khajoueinejad Muhammad O Ghani Andrew Hermina Alexander Mina Christina E Bailey Noah Cohen Daniel Labow Benjamin Golas Umut Sarpel Kamran Idrees Deepa Magge Source Type: research
More News: Bile | Cancer & Oncology | Carcinoma | Chemotherapy | Cholecystectomy | Hepatocellular Carcinoma | History of Medicine | Liver | Liver Cancer | Peritoneal Cancer | Study | Surgery | Urology & Nephrology | USA Health